承慶堂品牌怎么样 申请店铺

我要投票 承慶堂在医疗器械行业中的票数:652 更新时间:2026-01-26
承慶堂是哪个国家的品牌?「承慶堂」是 安徽承庆堂国药股份有限公司 旗下著名品牌。该品牌发源于安徽省亳州市,由创始人李整风在2012-01-17期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力承慶堂品牌出海!将品牌入驻外推网,定制承慶堂品牌推广信息,可以显著提高承慶堂产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

承慶堂怎么样

安徽承庆堂国药股份有限公司(原亳州正丰医药有限责任公司)是于2001年投资建设的集医疗器械生产与销售一体化公司,是一家集医疗器械的技术研发、技术咨询为产业核心,采用国际OEM模式,以掌控知识产权为入手、以医药科研为主的企业,主打“承庆堂”骨病系列外用贴剂产品,以疗效显著、品质稳定深得广大骨科医院及消费者的认可和好评。公司在医药行业经过短短几年的发展历程,依靠自身产品的绝对疗效已形成了骨病系列外用贴剂的知名品牌。“品质决定品牌”,创造骨病系列外用贴剂的医药品牌是正丰医药人孜孜不倦和执着追求的目标。

公司拥有一支团结、创新、奋进的技术研发队伍,在公司全体员工的共同努力下,企业坚持走专业化道路,形成了“材料来源基地化,检测手段科学化,制作工艺规范化,贴剂质量标准化,设计包装规格化”的“五化”管理模式,产品“选料上乘,工艺考究,疗效显著”。提升了“承庆堂”品牌的知名度和美誉度。始终坚持靠诚信打造自身品牌、靠质量占领市场先机、靠服务赢得行业机遇、靠管理推动企业发展的理念,在严峻的医药行业形势下,注重发挥自身优势,做大做强主营业务,我们坚信“一生只做一件事”,在同行业内取得了骄人的业绩,公司在发展过程中,得到了各级领导和相关职能管理部门的正确指引和极大的关怀,在广大医药流通企业和商业客户的支持下,在全国药业行业中,凭借自身实力和产品品质,铸就了企业在医药行业及广大骨科医院的巩固地位。目前,公司已与国内多家骨科医院和众多客户建立了紧密、稳固的合作关系,形成了强大的销售网络和品牌优势。公司也一直专注于现代企业制度的建设,目前已经在企业的产权结构、运营模式、管理制度、业务流程上达到了一定水平,并形成了自己的特色。

公司自2007年就尝试运作终端销售模式,即在有条件的骨科医院设立精品药房,截至目前已在国内多家骨科医院建立了上百家精品药房,此模式的成功运作,有利于实现名企、名院、名医、名品的优化组合,扩大医疗机构的服务范围,为患者提供疗效显著、价格合理的诚信医疗服务。我们诚邀各大骨科医院垂询来访,共筑合作平台,实现医药携手共赢发展。

在如今医药行业新的竞争和挑战中,我们将拥有更加广阔的医药市场。“海内存知己,天涯若比邻”,公司愿与全国各大骨科医院、连锁药房及各界的朋友真诚合作、共创辉煌!



Anhui chengqingtang State Pharmaceutical Co., Ltd. (formerly Bozhou Zhengfeng Pharmaceutical Co., Ltd.) is an integrated production and sales company of medical devices invested and constructed in 2001. It is an enterprise that focuses on technical research and development and technical consultation of medical devices, adopts the international OEM mode, controls intellectual property rights and focuses on medical research, and focuses on "chengqingtang" osteopathy A series of external patch products, with remarkable curative effect and stable quality, have won the recognition and praise of orthopedic hospitals and consumers. After just a few years of development in the pharmaceutical industry, relying on the absolute efficacy of its own products, the company has formed a well-known brand of bone disease series external patches. "Quality determines the brand" and creating a brand of external use of orthopedic patches is the goal of Zhengfeng pharmaceutical people. The company has a united, innovative and progressive technology research and development team. With the joint efforts of all employees, the company adheres to the path of specialization, forming a "five chemical" management mode of "base of material sources, scientific detection means, standardized production process, standardized paste quality, standardized design and packaging". The product "selects the best materials, exquisite technology, and curative effect" Remarkable. It has improved the popularity and reputation of chengqingtang brand. We always adhere to the concept of building our own brand by integrity, seizing the market opportunity by quality, winning industry opportunities by service, and promoting enterprise development by management. Under the severe situation of the pharmaceutical industry, we pay attention to giving full play to our own advantages and making our main business bigger and stronger. We firmly believe that "only one thing in life" has made remarkable achievements in the same industry. In the process of development, the company has obtained With the correct guidance and great care of leaders at all levels and relevant functional management departments, supported by the majority of pharmaceutical circulation enterprises and commercial customers, and with its own strength and product quality in the national pharmaceutical industry, the company has established a firm position in the pharmaceutical industry and the majority of orthopedic hospitals. At present, the company has established close and stable cooperative relations with many orthopedic hospitals and customers in China, forming a strong sales network and brand advantages. The company has also been focusing on the construction of modern enterprise system. At present, it has reached a certain level in the property right structure, operation mode, management system and business process of the enterprise, and has formed its own characteristics. Since 2007, the company has tried to operate terminal sales mode, that is, to set up boutique pharmacies in conditional orthopedic hospitals. Up to now, hundreds of boutique pharmacies have been set up in many orthopedic hospitals in China. The successful operation of this mode is conducive to the realization of the optimized combination of famous enterprises, famous hospitals, famous doctors and famous products, the expansion of the service scope of medical institutions, and the provision of significant curative effect and reasonable price for patients The integrity of medical services. We sincerely invite all orthopedic hospitals to visit us and build a cooperation platform to achieve win-win development of medicine. In today's new competition and challenges in the pharmaceutical industry, we will have a broader pharmaceutical market. "Friends in the sea, the end of the world is like a neighbor", the company is willing to sincerely cooperate with all major orthopedic hospitals, chain pharmacies and friends from all walks of life to create brilliant!

本文链接: https://brand.waitui.com/8a4ae9536.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

锋龙股份:将就股票交易波动情况进行停牌核查

36氪获悉,锋龙股份公告,因股票自2025年12月25日至2026年1月23日已连续17个交易日涨停,价格涨幅为405.74%,期间多次触及股票交易异常波动情形,公司股票短期内价格涨幅较大,已累积巨大交易风险,明显偏离市场走势,未来可能存在股价快速下跌的风险。为维护投资者利益,公司将就股票交易波动情况进行停牌核查。公司股票自2026年1月26日(星期一)开市起停牌,自核查结束并披露核查公告后复牌,预计停牌时间不超过5个交易日。

2小时前

“木头姐”:特斯拉的竞争优势在于其成本将比其他竞争对手低至少50%

“木头姐”凯西・伍德谈特斯拉Robotaxi,称目前正处于自动驾驶出租车市场兴起的初期阶段。根据她们团队的测算,特斯拉的竞争优势在于其成本将比其他竞争对手低至少50%。(财联社)

2小时前

嘉美包装:将就股票交易波动情况进行停牌核查

36氪获悉,嘉美包装公告,公司股票自2025年12月17日至2026年1月23日期间价格涨幅为408.11%,期间多次触及股票交易异常波动情形,公司股票短期内价格涨幅较大,已背离公司基本面,为维护投资者利益,公司将就股票交易波动情况进行停牌核查。公司股票自2026年1月26日(星期一)开市起停牌,预计停牌时间不超过5个交易日。

2小时前

上海沪工:股东明鑫光储拟减持不超3%公司股份

36氪获悉,上海沪工公告,公司持股5%以上股东上海明鑫光储企业管理有限公司因自身资金需求,计划自公告披露之日起15个交易日后的3个月内,通过集中竞价和大宗交易方式合计减持公司股份不超过1010.72万股,即不超过公司总股本的3%。其中,通过集中竞价减持不超过336.91万股,通过大宗交易减持不超过673.81万股。本次减持不设价格区间。

2小时前

东吴证券:基金四季报,透露了哪些重要线索?

36氪获悉,东吴证券发布研究报告称,截至1月22日,公募基金四季报已披露完毕。从市场主线来看,进入1月下旬后,年报业绩预告将进入密集披露期,市场主线将聚焦业绩线。东吴证券挖掘背后资金逻辑,提炼出四条核心线索,为后续大势研判与板块配置提供指引。

2小时前

本页详细列出关于承慶堂的品牌信息,含品牌所属公司介绍,承慶堂所处行业的品牌地位及优势。
咨询